Tag: Artificial Intelligence

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

OpenAI has acquired health-care technology startup Torch for about $60 million, according to a source familiar with the transaction.The financial details of the OpenAI...

Utah has started piloting autonomous service for the prescription renewals, as per an announcement that has been made from the Department of Commerce Office...

Adaptive clinical trials represent a revolutionary departure from traditional rigidly-designed study protocols by incorporating flexibility that allows trial parameters to adjust in real-time based on accumulating data and emerging evidence.